A therapeutic target is a substance located in any part of a cell capable of recognizing a drug and producing cellular response.
These drugs are designed to act against specific molecules (target molecules) required for tumour development by blocking or deactivating them, thus producing cellular death or impeding cell growth.
Levels of action
The most common drugs directed against molecular targets currently used can work on several levels. These are examples of drugs directed against molecular targets: trastuzumab, lapatinib, cetuximab, panitumumab,imatinib, erlotinib, gefitinib, sunitinib, bevacizumab, everolimus, temsirolimus, bortezomid, etc..
Medical Services
The IVO's specialisation in oncology allows for a service structure organised by care areas classified according to the type of tumour
Tumour Committees
The committees are the ultimate expression of multidisciplinary medicine. They are made up of expert physicians from the main oncological specialities.
Admission and Information
Any citizen with cancer or a certified oncological suspicion can apply to be a patient at the Instituto Valenciano de Oncología.
As it has an agreement with the Public Health System, patients do not have to assume any costs for their treatment.
